D R Strayer|S B Kahn - JoVE Visualize

Showing results (31-40 of 48) with videos related to

Pageof 5

Sort By:

Transplantation Proceedings|April 1, 1991

Cardiovascular hemodynamic effects of correction of anemia of chronic renal failure with recombinant-human erythropoietinA B Schwartz, J E Prior, G S Mintz, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 1994

A controlled clinical trial with a specifically configured RNA drug, poly(I).poly(C12U), in chronic fatigue syndromeD R Strayer, W A Carter, I Brodsky, et al.

In Vivo (Athens, Greece)|July 1, 1994

Ampligen inhibits human herpesvirus-6 in vitroD V Ablashi, Z N Berneman, M Williams, et al.

American Journal of Clinical Oncology|June 1, 1989

Attenuated high-dose cytosine arabinoside in the treatment of the elderly patient with acute nonlymphocytic leukemia. An Eastern Cooperative Oncology Group Pilot StudyS B Kahn, K Ebrahim, P Cassileth, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1992

Antitumor effects of interleukin-2 and mismatched double-stranded RNA, individually and in combination, against a human malignant melanoma xenograftH R Hubbell, H E Vargas, K L Tsujimoto, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1984

Full dose versus attenuated dose daunorubicin, cytosine arabinoside, and 6-thioguanine in the treatment of acute nonlymphocytic leukemia in the elderlyS B Kahn, C B Begg, J J Mazza, et al.

ASAIO Transactions|July 1, 1990

One year of rHuEPO therapy prolongs RBC survival and may stabilize RBC membranes despite natural progression of chronic renal failure to uremia and need for dialysisA B Schwartz, B Kelch, L Terzian, et al.

American Journal of Clinical Oncology|February 1, 1991

High-dose cytosine arabinoside and etoposide in the treatment of relapsed or refractory adult leukemiaJ Gryn, J Conroy, D Topolsky, et al.

Journal of Clinical Pharmacology|May 1, 1980

Effects of zomepirac on hemostasis in healthy adults and on platelet function in vitroC H Mielke, S B Kahn, L D Muschek, et al.

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 1, 1996

Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI:polyC12U in the treatment of HIV infectionK A Thompson, D R Strayer, P D Salvato, et al.

Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:

Pageof 5

Transplantation Proceedings|April 1, 1991

Cardiovascular hemodynamic effects of correction of anemia of chronic renal failure with recombinant-human erythropoietinA B Schwartz, J E Prior, G S Mintz, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 1994

A controlled clinical trial with a specifically configured RNA drug, poly(I).poly(C12U), in chronic fatigue syndromeD R Strayer, W A Carter, I Brodsky, et al.

In Vivo (Athens, Greece)|July 1, 1994

Ampligen inhibits human herpesvirus-6 in vitroD V Ablashi, Z N Berneman, M Williams, et al.

American Journal of Clinical Oncology|June 1, 1989

Attenuated high-dose cytosine arabinoside in the treatment of the elderly patient with acute nonlymphocytic leukemia. An Eastern Cooperative Oncology Group Pilot StudyS B Kahn, K Ebrahim, P Cassileth, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1992

Antitumor effects of interleukin-2 and mismatched double-stranded RNA, individually and in combination, against a human malignant melanoma xenograftH R Hubbell, H E Vargas, K L Tsujimoto, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1984

Full dose versus attenuated dose daunorubicin, cytosine arabinoside, and 6-thioguanine in the treatment of acute nonlymphocytic leukemia in the elderlyS B Kahn, C B Begg, J J Mazza, et al.

ASAIO Transactions|July 1, 1990

One year of rHuEPO therapy prolongs RBC survival and may stabilize RBC membranes despite natural progression of chronic renal failure to uremia and need for dialysisA B Schwartz, B Kelch, L Terzian, et al.

American Journal of Clinical Oncology|February 1, 1991

High-dose cytosine arabinoside and etoposide in the treatment of relapsed or refractory adult leukemiaJ Gryn, J Conroy, D Topolsky, et al.

Journal of Clinical Pharmacology|May 1, 1980

Effects of zomepirac on hemostasis in healthy adults and on platelet function in vitroC H Mielke, S B Kahn, L D Muschek, et al.

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 1, 1996

Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI:polyC12U in the treatment of HIV infectionK A Thompson, D R Strayer, P D Salvato, et al.

Pageof 5